Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Linsitinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 1172.00 | 966.75 | 1.2123 | 1.1191 |
| MCF 10A | Erlotinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 1322.00 | 966.75 | 1.3675 | 1.1972 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 312.50 | 96.23 | 119.00 | 966.75 | 0.1231 | 0.0659 |
| MCF 10A | 17-AAG | 0.000302 | uM | 9 | 312.50 | 96.23 | 1045.00 | 966.75 | 1.0809 | 1.0473 |
| MCF 10A | Lapatinib | 3.1623 | uM | 9 | 312.50 | 96.23 | 385.00 | 966.75 | 0.3982 | 0.5167 |
| MCF 10A | 17-AAG | 0.31623 | uM | 9 | 312.50 | 96.23 | 62.00 | 966.75 | 0.0641 | -0.1237 |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 985.00 | 966.75 | 1.0189 | 1.0113 | |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 1015.00 | 966.75 | 1.0499 | 1.0295 | |
| MCF 10A | Linsitinib | 1 | uM | 9 | 312.50 | 96.23 | 317.00 | 966.75 | 0.3279 | 0.4307 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 312.50 | 96.23 | 522.00 | 966.75 | 0.5400 | 0.6620 |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 1084.00 | 966.75 | 1.1213 | 1.0700 | |
| MCF 10A | Linsitinib | 19.9526 | uM | 9 | 312.50 | 96.23 | 120.00 | 966.75 | 0.1241 | 0.0686 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 96.23 | 695.00 | 966.75 | 0.7189 | 0.8112 |
| MCF 10A | Erlotinib | 10 | uM | 9 | 312.50 | 96.23 | 88.00 | 966.75 | 0.0910 | -0.0265 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 312.50 | 96.23 | 136.00 | 966.75 | 0.1407 | 0.1095 |
| MCF 10A | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 96.23 | 1421.00 | 966.75 | 1.4699 | 1.2454 |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 312.50 | 96.23 | 1547.00 | 966.75 | 1.6002 | 1.3034 |
| MCF 10A | Linsitinib | 0.01 | uM | 9 | 312.50 | 96.23 | 1470.00 | 966.75 | 1.5206 | 1.2683 |
| MCF 10A | 17-AAG | 0.0001 | uM | 9 | 312.50 | 96.23 | 1623.00 | 966.75 | 1.6788 | 1.3368 |
| MCF 10A | 17-AAG | 0.01 | uM | 9 | 312.50 | 96.23 | 188.00 | 966.75 | 0.1945 | 0.2229 |
| MCF 10A | Linsitinib | 10 | uM | 9 | 312.50 | 96.23 | 272.00 | 966.75 | 0.2814 | 0.3664 |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 1250.00 | 966.75 | 1.2930 | 1.1605 | |
| MCF 10A | Lapatinib | 1 | uM | 9 | 312.50 | 96.23 | 995.00 | 966.75 | 1.0292 | 1.0174 |
| MCF 10A | Lapatinib | 10 | uM | 9 | 312.50 | 96.23 | 79.00 | 966.75 | 0.0817 | -0.0575 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 96.23 | 985.00 | 966.75 | 1.0189 | 1.0113 |